首页 | 本学科首页   官方微博 | 高级检索  
     

国产利培酮治疗脑血管病所致伴有精神障碍疗效分析
引用本文:李国兰,孟凤华,冷树东. 国产利培酮治疗脑血管病所致伴有精神障碍疗效分析[J]. 中国民族民间医药杂志, 2010, 19(14): 81-82
作者姓名:李国兰  孟凤华  冷树东
作者单位:吉林市第六人民医院,吉林吉林132011
摘    要:目的:探讨国产利培酮(思利舒)治疗脑血管所致精神障碍的疗效和安全性。方法:随机抽取脑血管病所致精神障碍30例,用思利舒治疗,并分别于治疗前及治疗后第1、2、4、8周末采用简明精神病量表BPRS,阳性与阴性症状量表(PANSS)及副反应量表(TESS)评定临床疗效及不良反应。结果:BPRS总分,PANSS总分和各症状评分较治疗前显著降低,且有显著差异(P〈0.01-0.05),有效率,90%显效率,63%;常见不良反应是体重增加和静坐不能。结论:思利舒对脑血管病所致精神障碍安全有效,不良反应少,经济适用,值得临床推广使用。

关 键 词:利培酮(思利舒)  脑血管病所致精神障碍

Study of domestic risperidone in the treatment of mental disorders due to Cerebral Vascular Disease Efficacy
Li Guolan,Meng Fenghua,Leng Shudong. Study of domestic risperidone in the treatment of mental disorders due to Cerebral Vascular Disease Efficacy[J]. Chinese Journal of Ethnomedicine and Ethnopharmacy, 2010, 19(14): 81-82
Authors:Li Guolan  Meng Fenghua  Leng Shudong
Affiliation:Sixth People’s Hospital in Jilin City,Li Guolan,Meng Fenghua,Leng Shudong
Abstract:Objective:To explore the domestic risperidone(Sili Shu) in the treatment of mental disorders due to Cerebral Vascular Disease the efficacy and safety.Methods:Arandom sample of mental disorders due to vascular disease,30 cases treated with Sili Shu,respectively,before treatment and after treatment in the fi rst 1,2,4,8 to Brief Psychiatric Rating Scale(BPRS),Positive and Negative Syndrome Scale(PANSS) and side effects scale(TCSS) assessed the efficacy and adverse reactions.Results: BPRS total score,PANSS tot...
Keywords:risperidone(Sili Shu)  mental disorders due to Cerebral Vascular Disease  
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号